Mount Elbrus Mount Elbrus Mount Elbrus (; , "Miñi taw" or "Mın̨i tau" ; , "’Wāśhamāxwa" or "Ꜧuas̨hamaxua" ;) could be considered the highest mountain in Europe, notwithstanding the fact that Caucasus mountains are at the intersection of Europe and Asia, and the tenth most prominent peak in the world. A dormant volcano, Elbrus is in the Caucasus Mountains in Southern Russia, near the border with Georgia. Elbrus has two summits, both of which are dormant volcanic domes. The taller west summit is ; the east summit is . The east summit was first ascended on 10 July 1829 (Julian calendar) by
MT-45 States the DEA placed MT-45 in Schedule 1 of the Controlled Substance Act. This took effect January 12, 2018. MT-45 MT-45 (IC-6) is an opioid analgesic drug invented in the 1970s by Dainippon Pharmaceutical Co. It is chemically a 1-substituted-4-(1,2-diphenylethyl)piperazine derivative, which is structurally unrelated to most other opioid drugs. Racemic MT-45 has around 80% the potency of morphine, with almost all opioid activity residing in the (S) enantiomer (the opposite stereochemistry from the related drug lefetamine). It has been used as a lead compound from which a large family of potent opioid drugs have been developed, including full agonists,